BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34674139)

  • 21. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β- induced Epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Maleki N; Abbasi M; Abazari O; Shabanzadeh M; Khanicheragh P
    Gene; 2021 Aug; 794():145774. PubMed ID: 34126197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L- and D-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation.
    Wagner W; Ciszewski WM; Kania KD
    Cell Commun Signal; 2015 Jul; 13():36. PubMed ID: 26208712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.
    Zanotto-Filho A; Masamsetti VP; Loranc E; Tonapi SS; Gorthi A; Bernard X; Gonçalves RM; Moreira JC; Chen Y; Bishop AJ
    Mol Cancer Ther; 2016 Dec; 15(12):3000-3014. PubMed ID: 27638861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of hydrogen on cervical cancer suppression revealed by high‑throughput RNA sequencing.
    Chu J; Gao J; Wang J; Li L; Chen G; Dang J; Wang Z; Jin Z; Liu X
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
    Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
    Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
    Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
    Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.
    Hyeon S; Lee H; Yang Y; Jeong W
    Free Radic Biol Med; 2013 Dec; 65():789-799. PubMed ID: 23954472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancer.
    Wang M; Xue Y; Shen L; Qin P; Sang X; Tao Z; Yi J; Wang J; Liu P; Cheng H
    Redox Biol; 2019 Jun; 24():101225. PubMed ID: 31136958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
    Wang T; Liu Z; Shi F; Wang J
    Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GSH depletion and consequent AKT inhibition contribute to the Nrf2 knockdown-induced decrease in proliferation in glioblastoma U251 cells.
    Jia Y; Wang HD; Wang Q; Ding H; Wu HM; Pan H
    Oncol Rep; 2017 Apr; 37(4):2252-2260. PubMed ID: 28260004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer.
    Luo C; Fan W; Jiang Y; Zhou S; Cheng W
    Med Sci Monit; 2018 Apr; 24():2197-2209. PubMed ID: 29650944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines.
    Sood S; Srinivasan R
    Mol Cell Biochem; 2015 Jun; 404(1-2):181-91. PubMed ID: 25772483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-cancer activity of Conyza blinii saponin against cervical carcinoma through MAPK/TGF-β/Nrf2 signaling pathways.
    Peng L; Hu C; Zhang C; Lu Y; Man S; Ma L
    J Ethnopharmacol; 2020 Apr; 251():112503. PubMed ID: 31891798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
    Li N; Sun C; Zhou B; Xing H; Ma D; Chen G; Weng D
    PLoS One; 2014; 9(7):e100314. PubMed ID: 24999622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells.
    Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential impact of trigonelline loaded micelles on Nrf2 suppression to overcome oxaliplatin resistance in colon cancer cells.
    Pirpour Tazehkand A; Salehi R; Velaei K; Samadi N
    Mol Biol Rep; 2020 Aug; 47(8):5817-5829. PubMed ID: 32661875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nujiangexathone A, a Novel Compound Derived from Garcinia nujiangensis, Induces Caspase-Dependent Apoptosis in Cervical Cancer through the ROS/JNK Pathway.
    Zhang L; Kong SY; Zheng ZQ; Meng XX; Feng JL; Tan HS; Lao YZ; Xiao LB; Xu HX
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27754347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.